The study highlights Juncell Therapeutics' breakthroughs in TIL process development, demonstrating that its proprietary feeder-free system can generate robust, functional TILs from both "hot" and ...

DEBORAH JAMES would be geeking out if she knew her nickname is now etched on the door of one of Britain’s leading cancer ...

Auron Therapeutics, a clinical-stage biotechnology company targeting cell-state plasticity to improve patient outcomes in oncology and inflammatory disease, today announced preclinical data in ...

The future of high-end materials might just lie buried in prehistoric dinosaur times. Creative powerhouse VML, genomic ...

Q1 2025 Earnings Conference Call April 28, 2025 8:00 AM ETCompany ParticipantsSteve Willoughby - Senior Vice President, ...